| Dr Ravi B Patel, MD | |
|
5080 Spectrum Dr Ste 1000e, Addison, TX 75001-6444 | |
| (214) 973-3792 | |
| Not Available |
| Full Name | Dr Ravi B Patel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 5080 Spectrum Dr Ste 1000e, Addison, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093764169 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M3058 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspen Hospice Care Inc | Lewisville, TX | Hospice |
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blue Star Rehabilitation, Llc | 2062842008 | 2 |
| Questcare Hospitalists Pllc | 5799785119 | 318 |
News Archive
The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.
Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.
A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 8 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.
Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.
A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 8 days ago
| Entity Name | Perpetuum Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699144154 PECOS PAC ID: 9234430521 Enrollment ID: O20151210000285 |
News Archive
The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.
Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.
A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 8 days ago
| Entity Name | Blue Star Rehabilitation, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588051114 PECOS PAC ID: 2062842008 Enrollment ID: O20200415002217 |
News Archive
The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.
Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.
A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ravi B Patel, MD 5080 Spectrum Dr Ste 1000e, Addison, TX 75001-6444 Ph: (214) 973-3792 | Dr Ravi B Patel, MD 5080 Spectrum Dr Ste 1000e, Addison, TX 75001-6444 Ph: (214) 973-3792 |
News Archive
The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.
Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.
A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 8 days ago
Aneesha A. Asher, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 | |
Soumya Yemme, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd Ste 620, Addison, TX 75001 Phone: 972-249-0200 | |
Syed A Imam, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 | |
Alexander Hung Tran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 | |
Shabaz Ali Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 | |
Dr. Hayan A. Orfaly, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 |